Biologics Contract Manufacturing Market to Hit US$ 83.47 Billion by 2033 | Top Companies 2026 - WuXi Biologics, AGC Biologics, Lonza

Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.

Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/biologics-contract-manufacturing-market?prasad

DataM Intelligence unveils exclusive insights into the Biologics Contract Manufacturing Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by identifying high-growth segments and reducing investment risks through actionable forecasts. With in-depth competitive benchmarking, it enables smarter strategies and confident decision-making. Leveraging these insights allows stakeholders to stay ahead of market shifts and maximize returns.

Biologics Contract Manufacturing Market Major Players:

Wuxi Biologics, AGC Biologics, Lonza, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific Inc., KBI Biopharma, Vetter Pharma, Recipharm AB., Abzena Ltd, Samsung Biologics, Eurofins CDMO, Catalent, Boehringer Ingelheim International GmbH, among others.

Segment Covered in the Biologics Contract Manufacturing Market:

➥ By Product Type: Monoclonal Antibodies, Recombinant Proteins, Cell and Gene Therapies, Vaccines, Others
➥ By Platform: Mammalian, Microbial, Others
➥ By Application: Oncology, Metabolic Diseases, Autoimmune Diseases, Ophthalmology, Infectious Diseases, Cardiovascular Diseases, Others

Find the Right Partner to Accelerate Your Growth Today with Our Latest Report:
https://www.datamintelligence.com/partner-identification-enquiry/biologics-contract-manufacturing-market?prasad

United States: Recent Industry Developments

✅ In March 2026, Lonza Group expanded biologics manufacturing capacity in the U.S. to meet rising demand for cell and gene therapies. The initiative improves production scalability. Lonza continues strengthening CDMO services.
✅ In February 2026, Thermo Fisher Scientific expanded biologics contract manufacturing services with new facilities. The development supports pharma outsourcing. Thermo Fisher continues advancing CDMO capabilities.
✅ In January 2026, Catalent, Inc. enhanced biologics production technologies for improved yield and efficiency. The innovation supports drug development. Catalent continues strengthening manufacturing services.
✅ In December 2025, Samsung Biologics (U.S. operations) expanded contract manufacturing services for biologics. The initiative supports global pharmaceutical demand. Samsung continues strengthening CDMO presence.

Japan: Recent Industry Developments

✅ In March 2026, Fujifilm Diosynth Biotechnologies expanded biologics manufacturing capacity in Japan. The initiative supports global pharma demand. Fujifilm continues strengthening CDMO services.
✅ In February 2026, AGC Biologics enhanced contract manufacturing services for biopharmaceuticals. The development improves production efficiency. AGC continues advancing biologics manufacturing.
✅ In January 2026, Takeda expanded biologics production capabilities for internal and external manufacturing. The initiative supports pipeline growth. Takeda continues strengthening manufacturing.
✅ In December 2025, Daiichi Sankyo enhanced biologics manufacturing processes for improved scalability. The development supports oncology drugs. Daiichi Sankyo continues advancing production capabilities.

Biologics Contract Manufacturing Market Growth:

The biologics contract manufacturing market is driven by increasing demand for biologic drugs and vaccines. Rising outsourcing by pharmaceutical companies is boosting demand for contract manufacturing services. Technological advancements in bioprocessing and cell culture are improving production efficiency. Growing pipeline of biologics and biosimilars is supporting market growth. Additionally, regulatory support for biologics is encouraging investment.

Market expansion is further supported by partnerships between biopharma companies and contract manufacturers. Increasing focus on cost optimization and scalability is driving outsourcing. Expansion of manufacturing facilities is improving capacity. Rising demand for personalized medicine is boosting biologics production. Moreover, advancements in automation and single-use technologies are enhancing efficiency.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/biologics-contract-manufacturing-market?prasad

Data-Driven Research Methodology for the Biologics Contract Manufacturing Market:

Our research process for the Biologics Contract Manufacturing Market at DataM Intelligence combines rigorous primary and secondary research to ensure accurate and reliable insights. We engage with industry experts, key stakeholders, and validated data sources to capture real-time market dynamics. Advanced analytical tools and proprietary models are applied to forecast trends, competitive landscapes, and growth opportunities. Each report undergoes multi-level validation to deliver actionable intelligence that supports strategic decision-making.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=biologics-contract-manufacturing-market?prasad

Benefits You Gain from This Report

➡️Authoritative Market Analysis
The report provides a structured evaluation of current market conditions, including validated drivers, restraints, and emerging opportunities, enabling organizations to align strategies with real market dynamics.

➡️Robust and Transparent Forecasting
Market size estimates and growth projections are developed using proven research methodologies and verified data sources, ensuring consistency, accuracy, and reliability for business planning.

➡️Clear Competitive Intelligence
Gain a comprehensive understanding of key market participants, including their strategic initiatives, product offerings, and positioning, allowing for effective competitive benchmarking and response planning.

➡️Granular Segment Insights
Detailed breakdowns by segment, application, and end-user provide clarity on high-growth areas, helping businesses prioritize investments and target the most profitable opportunities.

➡️Region-Specific Strategic Insights
The report delivers actionable intelligence across major geographies, enabling companies to identify region-specific growth trends, demand patterns, and expansion opportunities.

➡️Decision-Ready Data and Insights
All findings are presented in a structured, easy-to-interpret format, allowing stakeholders to translate data into clear business actions, whether for market entry, expansion, or portfolio optimization.

➡️Opportunity and Risk Assessment
The study highlights key investment pockets while also outlining potential risks and market uncertainties, supporting balanced and informed decision-making.

➡️Customization and Expert Support
Clients have access to tailored insights and direct engagement with analysts to address specific business questions, ensuring the report's relevance to strategic objectives.

Most Frequently Asked Questions in the Biologics Contract Manufacturing Market Research Industry:

➠ How big is the Biologics Contract Manufacturing Market in 2026?
➠ What growth opportunities and market challenges do Biologics Contract Manufacturing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Biologics Contract Manufacturing market growth?
➠ Who are the key players in Biologics Contract Manufacturing Market?

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us-
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.